Clinical practice The management of hyperammonemia

被引:89
作者
Haeberle, Johannes [1 ]
机构
[1] Univ Childrens Hosp Zurich, Div Metab, Kinderspital Zurich, CH-8032 Zurich, Switzerland
关键词
Ammonia; Glutamine; Urea cycle; Nitrogen metabolism; Awareness; Neurotoxicity; Cerebral edema; UREA-CYCLE DISORDERS; ORNITHINE TRANSCARBAMYLASE DEFICIENCY; ALTERNATIVE PATHWAY THERAPY; PORTAL-SYSTEMIC ENCEPHALOPATHY; AMINO-ACID-METABOLISM; NITROGEN-METABOLISM; AMMONIA TOXICITY; NEONATAL HYPERAMMONEMIA; NUTRITIONAL MANAGEMENT; HEPATIC-ENCEPHALOPATHY;
D O I
10.1007/s00431-010-1369-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hyperammonemia is a life-threatening condition which can affect patients at any age. Elevations of ammonia in plasma indicate its increased production and/or decreased detoxification. The hepatic urea cycle is the main pathway to detoxify ammonia; it can be defective due to an inherited enzyme deficiency or secondary to accumulated toxic metabolites or substrate depletion. Clinical signs and symptoms in hyperammonemia are unspecific but they are mostly neurological. Thus, in any unexplained change in consciousness or in any unexplained encephalopathy, hyperammonemia must be excluded as fast as possible. Any delay in recognition and start of treatment of hyperammonemia may have deleterious consequences for the patient. Treatment largely depends on the underlying cause but is, at least in pediatric patients, mainly aimed at establishing anabolism to avoid endogenous protein breakdown and amino acid imbalances. In addition, pharmacological treatment options exist to improve urea cycle function or to remove nitrogen, but their use depend on the underlying disorder. To improve the prognosis of acute hyperammonemia, an increased awareness of this condition is probably more needed than anything else. Likewise, the immediate start of appropriate therapy is of utmost importance. This review focuses on a better understanding of factors leading to ammonia elevations and on practical aspects related to diagnosis and treatment in order to improve clinical management of hyperammonemia.
引用
收藏
页码:21 / 34
页数:14
相关论文
共 69 条
[1]   Glutamine: A Trojan horse in ammonia neurotoxicity [J].
Albrecht, Jan ;
Norenberg, Michael D. .
HEPATOLOGY, 2006, 44 (04) :788-794
[2]   LACTULOSE - REVIEW OF ITS THERAPEUTIC AND PHARMACOLOGICAL PROPERTIES WITH PARTICULAR REFERENCE TO AMMONIA METABOLISM AND ITS MODE OF ACTION IN PORTAL SYSTEMIC ENCEPHALOPATHY [J].
AVERY, GS ;
BROGDEN, RN ;
DAVIES, EF .
DRUGS, 1972, 4 (1-2) :7-&
[3]   Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation [J].
Bachmann, C .
EUROPEAN JOURNAL OF PEDIATRICS, 2003, 162 (06) :410-416
[4]   Mechanisms of hyperammonemia [J].
Bachmann, C .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2002, 40 (07) :653-662
[5]  
Bachmann C, 2006, PATHOPHYSIOLOGY MANA, P157
[6]  
Bachmann C, 2003, PHYS GUIDE LAB DIAGN, P261
[7]   Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy [J].
Barrueto, F ;
Hack, JB .
ACADEMIC EMERGENCY MEDICINE, 2001, 8 (10) :999-1001
[8]   Measurement of ammonia in blood [J].
Barsotti, RJ .
JOURNAL OF PEDIATRICS, 2001, 138 (01) :S11-S19
[9]   Alternative pathway therapy for urea cycle disorders: Twenty years later [J].
Batshaw, ML ;
MacArthur, RB ;
Tuchman, M .
JOURNAL OF PEDIATRICS, 2001, 138 (01) :S46-S54
[10]   Current concepts in the pathogenesis of urea cycle disorders [J].
Braissant, Olivier .
MOLECULAR GENETICS AND METABOLISM, 2010, 100 :S3-S12